Insulet (PODD) Misses Q4 EPS by 4c, Revs Beat
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $151.98 +2.67%
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.15 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
- Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
